VIVACTIL Drug Patent Profile
✉ Email this page to a colleague
When do Vivactil patents expire, and what generic alternatives are available?
Vivactil is a drug marketed by Chartwell Rx and Teva Womens and is included in three NDAs.
The generic ingredient in VIVACTIL is protriptyline hydrochloride. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the protriptyline hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vivactil
A generic version of VIVACTIL was approved as protriptyline hydrochloride by HIKMA on September 16th, 2008.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VIVACTIL?
- What are the global sales for VIVACTIL?
- What is Average Wholesale Price for VIVACTIL?
Summary for VIVACTIL
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 29 |
| Patent Applications: | 4,254 |
| DailyMed Link: | VIVACTIL at DailyMed |
US Patents and Regulatory Information for VIVACTIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Rx | VIVACTIL | protriptyline hydrochloride | TABLET;ORAL | 073644-001 | Aug 24, 1995 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Teva Womens | VIVACTIL | protriptyline hydrochloride | TABLET;ORAL | 016012-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Chartwell Rx | VIVACTIL | protriptyline hydrochloride | TABLET;ORAL | 073645-001 | Aug 24, 1995 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Teva Womens | VIVACTIL | protriptyline hydrochloride | TABLET;ORAL | 016012-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
